Current Report Filing (8-k)
June 30 2020 - 9:29AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): June 30, 2020
CYTRX
CORPORATION
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
000-15327
|
|
58-1642740
|
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
11726
San Vicente Boulevard, Suite 650
Los
Angeles, California 90049
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (310) 826-5648
Former
name or former address, if changed since last report: None
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
[X]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
|
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
|
Common
Stock, par value $0.001 per share
|
|
CYTR
|
|
OTC
Markets
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth
company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
8.01 Other Events
On
June 30, 2020, CytRx Corporation (the “Company”) filed with the Securities and Exchange Commission a supplement
to its definitive proxy statement, dated June 12, 2020, relating to the Company’s 2020 Annual Meeting of Stockholders scheduled
for July 30, 2020. The supplement should be read in conjunction with the Company’s definitive proxy statement, which remains
unchanged except as specifically amended by the supplement. A copy of the proxy supplement is included as Exhibit 99.1 to this
report and is incorporated by reference herein.
Item
9.01 Financial Statement and Exhibits.
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
|
CYTRX
CORPORATION
|
|
|
|
|
|
Date:
June 30, 2020
|
|
/s/
John Y. Caloz
|
|
|
|
John
Y. Caloz
|
|
|
|
Chief
Financial Officer
|
CytRx (QB) (USOTC:CYTR)
Historical Stock Chart
From Mar 2024 to Apr 2024
CytRx (QB) (USOTC:CYTR)
Historical Stock Chart
From Apr 2023 to Apr 2024
